Crossmark Global Holdings Inc. Sells 1,830 Shares of Masimo Co. (MASI)

Crossmark Global Holdings Inc. reduced its holdings in Masimo Co. (NASDAQ:MASI) by 24.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,566 shares of the medical equipment provider’s stock after selling 1,830 shares during the period. Crossmark Global Holdings Inc.’s holdings in Masimo were worth $598,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. FMR LLC boosted its position in Masimo by 6,605.4% during the second quarter. FMR LLC now owns 1,821,994 shares of the medical equipment provider’s stock valued at $177,918,000 after purchasing an additional 1,794,822 shares during the last quarter. Oakbrook Investments LLC boosted its position in Masimo by 28.7% during the third quarter. Oakbrook Investments LLC now owns 6,500 shares of the medical equipment provider’s stock valued at $810,000 after purchasing an additional 1,450 shares during the last quarter. First Trust Advisors LP boosted its position in Masimo by 1,123.4% during the third quarter. First Trust Advisors LP now owns 137,096 shares of the medical equipment provider’s stock valued at $17,074,000 after purchasing an additional 125,890 shares during the last quarter. Security Asset Management boosted its position in Masimo by 4.4% during the third quarter. Security Asset Management now owns 12,834 shares of the medical equipment provider’s stock valued at $1,598,000 after purchasing an additional 539 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in Masimo by 5.1% during the third quarter. Russell Investments Group Ltd. now owns 31,916 shares of the medical equipment provider’s stock valued at $3,973,000 after purchasing an additional 1,560 shares during the last quarter. 87.36% of the stock is currently owned by institutional investors and hedge funds.

NASDAQ:MASI opened at $128.43 on Thursday. The company has a market capitalization of $6.88 billion, a price-to-earnings ratio of 52.42, a price-to-earnings-growth ratio of 2.70 and a beta of 1.07. Masimo Co. has a 12-month low of $81.56 and a 12-month high of $130.00.

MASI has been the subject of several recent research reports. Piper Jaffray Companies raised Masimo from a “neutral” rating to an “overweight” rating and set a $120.00 price target for the company in a research report on Wednesday, December 19th. Zacks Investment Research raised Masimo from a “hold” rating to a “buy” rating and set a $115.00 price target for the company in a research report on Monday, November 26th. Needham & Company LLC reissued a “buy” rating and set a $139.00 price target on shares of Masimo in a research report on Friday, February 1st. BidaskClub cut Masimo from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 3rd. Finally, UBS Group began coverage on Masimo in a research note on Tuesday, November 27th. They issued a “buy” rating and a $137.00 price objective on the stock. One research analyst has rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $121.86.

In other Masimo news, Director Sanford Fitch sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, December 3rd. The stock was sold at an average price of $110.90, for a total value of $221,800.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Anand Sampath sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $110.00, for a total value of $3,300,000.00. The disclosure for this sale can be found here. Insiders sold 68,000 shares of company stock worth $7,691,800 in the last 90 days. Corporate insiders own 12.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was reported by Enterprise Leader and is the property of of Enterprise Leader. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://theenterpriseleader.com/2019/02/14/crossmark-global-holdings-inc-sells-1830-shares-of-masimo-co-masi.html.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Read More: How Investors Can Profit from Options Trading

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.